Therapy of varicella-zoster virus infection--mechanism of action of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
D000630:Aminopterin / Q000494:pharmacology; D000998:Antiviral Agents; D001973:Bromodeoxyuridine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D002460:Cell Line; D002644:Chickenpox / Q000188:drug therapy*; D004261:DNA Replication / Q000187:drug effects; D004279:DNA, Viral / Q000096:biosynthesis; D004259:DNA-Directed DNA Polymerase / Q000378:metabolism; D004352:Drug Resistance, Microbial; D006562:Herpes Zoster / Q000188:drug therapy*; D014645:Herpesvirus 3, Human / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development; D006801:Humans; D007124:Immunoenzyme Techniques; D066298:In Vitro Techniques; D007700:Kinetics; D009154:Mutation; D013937:Thymidine Kinase / Q000235:genetics / Q000378:metabolism; D010948:Viral Plaque Assay; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D004279:DNA, Viral; C020235:brivudine; D013937:Thymidine Kinase; D004259:DNA-Directed DNA Polymerase; D001973:Bromodeoxyuridine; D000630:Aminopterin